Lonza | LONN - Fremdkapital

Aktienkurs
511.20
Täglich Wechseln
8.20 1.63%
Monatlich
2.51%
Jährlich
1.23%
Q2 Prognose
499.29




Fremdkapital Veränderung Datum
Akzo Nobel EUR 3.67B 13M 2025-12
Alcon AG USD 4.59B 0 2025-12
Almirall EUR 324.81M 61.32M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
BASF EUR 18.48B 447M 2025-12
Bayer EUR 31.83B 877M 2025-12
Beiersdorf EUR 117M 15M 2025-12
Covestro EUR 1.67B 408M 2025-12
Demant DKK 18.98B 3.71B 2025-12
Fresenius EUR 10.8B 1.49B 2025-09
Fresenius Medical Care EUR 4.85B 4.49B 2025-12
Geberit CHF 1.35B 25.4M 2025-09
Genmab DKK 5.14B 5.01B 2025-12
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
GN Store Nord DKK 8.9B 9M 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Johnson Matthey GBP 1.34B 3M 2025-12
Merck EUR 10.73B 277M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Philips EUR 6.93B 303M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Sika AG CHF 4.13B 1.4B 2025-12
Smith & Nephew USD 3.3B 22M 2025-12
Solvay EUR 1.84B 209M 2025-12
UCB EUR 2.18B 634M 2025-12